BfArM approvals from DCP procedure for Rivastigmin patches granted for Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic
On 28 August 2015, the BfArM granted approvals from DCP procedures for rivastigmin patches at doses 4.6 mg/24 h and 9.5 mg/24 h for Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic.
On August 28, 2015, the BfArM received approvals from the DCP process for rivastigmine patches in the dosages 4.6 mg / 24 h and 9.5 mg / 24 h for the countries Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic granted.